Researchers planning a randomised control trial should consider excluding participants at increased risk of death during the follow-up period, while clinicians discussing surgical options with their patients may wish to consider life expectancy when choosing between ''combined'' entropion surgery and more straightforward everting sutures.
Dear Sir,
We read with great interest the recent article by Nakos et al. that showed the lateral tarsal strip (LTS) to have superior surgical success rates and reduction of symptoms than Quickert everting sutures (ES) in the repair of primary involutional lower eyelid entropion after one year [1] . We wish to complement their findings with those of our own Yorkshire Entropion Study (not previously published)-a randomised controlled trial with long-term (12-year) follow-up in which we attempt to compare two techniques for the surgical correction of involutional entropion.
Nakos et al. discuss the two key causative factors in primary involutional lower eyelid entropion (horizontal lid laxity, mainly due to senile lateral canthal tendon elongation or dehiscence, and vertical laxity, due to detachment of the inferior retractors from the tarsus) and have designed a study that evaluates the comparative success rates of repairs that address either the horizontal (LTS) or vertical (ES) component. In the Yorkshire Entropion Study we have compared two different ''combined'' procedures that address both components simultaneously-LTS plus ES vs. LTS plus Jones retractor plication. The primary outcome measure was success (no need for further surgery) vs. failure (need for further surgery) at two-year follow-up, although data collection was possible beyond this time point, the results of which are presented here.
Our study was granted ethical approval by the Leeds Teaching Hospital NHS Trust research ethics committee. This study adhered to the tenets of the Declaration of Helsinki, and informed consent was obtained from all study participants. Ninety-nine participants (mean age = 77 years, range 60-92) were recruited into the study between The main limitation of our study is the large source of potential bias created by the number of participants (n = 40) removed from the study. Furthermore, if we limit our analysis to only the 31 patients with follow-up data beyond three months the study becomes underpowered, such that comparative analysis would not achieve statistical significance. Finally, one-year follow-up is sufficient to compare the efficacy of two contrasting procedures such as ES vs. LTS, but is too short to identify the more subtle differences between more similar procedures such as LTS ? ES vs. LTS ? Jones, given their excellent success rates.
We wish to use our randomised trial to highlight the difficulties of performing studies that require a longer follow-up period in an elderly cohort with an increased mortality rate. Nonetheless, our findings suggest that ''combined'' entropion surgery (either LTS ? ES or LTS ? Jones) offers good long-term success. Researchers planning a randomised control trial should consider excluding participants at increased risk of death during the follow-up period, while clinicians discussing surgical options with their patients may wish to consider life expectancy when choosing between ''combined'' entropion surgery and more straightforward everting sutures.
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